Table 2

Concordance between PODXL expression in primary colorectal tumours and corresponding lymph node metastases
Tumour PODXL No of Evaluable PODXL pos PODXL neg Concordance
Patient location prim tumour ln met ln met ln met (%) ln met (%) (%)
1 Colon Pos 4 4 25 75 25
2 Colon Pos 3 3 33.3 66.7 33.3
3 Colon Pos 20 17 58.8 41.2 58.8
4 Colon Pos 3 3 66.7 33.3 66.7
5 Colon Pos 5 5 80 20 80
6 Colon Pos 6 5 80 20 80
7 Colon Pos 2 2 100 0 100
8 Colon Pos 2 2 100 0 100
9 Rectum Pos 10 10 80 20 80
10 Rectum Pos 2 2 100 0 100
11 Rectum Pos 3 3 100 0 100
12 Colon Neg 14 14 0 100 100
13 Colon Neg 2 2 0 100 100
14 Colon Neg 2 1 0 100 100
15 Colon Neg 3 3 0 100 100
16 Colon Neg 1 1 0 100 100
17 Colon Neg 5 5 0 100 100
18 Colon Neg 1 1 0 100 100
19 Colon Neg 14 14 0 100 100
20 Colon Neg 1 1 0 100 100
21 Rectum Neg 4 3 0 100 100
22 Rectum Neg 2 2 0 100 100
23 Rectum Neg 1 1 0 100 100
24 Rectum Neg 8 6 0 100 100
25 Rectum Neg 1 1 0 100 100
26 Rectum Neg 3 2 0 100 100
27 Rectum Neg 1 1 0 100 100
28 Rectum Neg 5 5 0 100 100
29 Rectum Neg 2 1 0 100 100
30 Rectum Neg 1 1 0 100 100
31 Rectum Neg 9 9 0 100 100

Larsson et al.

Larsson et al. Diagnostic Pathology 2013 8:109   doi:10.1186/1746-1596-8-109

Open Data